{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T18:24:23Z","timestamp":1751912663448,"version":"3.40.4"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Several hereditary myopathies that can predispose to malignant hyperthermia (MH) are reported. However, the risk of MH in myotonic dystrophy type I (DM1) has been suggested equal to general population, although the evidence is limited to only a few case reports.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We encountered a rare case of MH during anesthesia induction with sevoflurane in a male adolescent with previously undiagnosed DM1.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>After the event, genetic testing revealed the presence of a previously unknown heterozygous missense mutation in ryanodine receptor 1 (<jats:italic toggle=\"yes\">RYR1<\/jats:italic>) associated with MH (c.6898T\u200a&gt;\u200aC; p.ser2300Pro). Concomitantly, the patient was diagnosed with DM1 with abnormal cytosine-thymine-guanine triplet expansion in the <jats:italic toggle=\"yes\">DMPK<\/jats:italic> gene.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Dantrolene was administered to treat the hypermetabolic manifestations in 20\u200aminutes after the identification of MH.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient was successfully treated and discharged without any complications. Laboratory abnormalities were recovered to baseline at postoperative 4\u200adays.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>The authors suggest that possible MH susceptibility in DM1 patients may be refocused. Genetic testing can be a screening tool for MH susceptibility in these population, prior to receiving general anesthesia.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000025859","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T15:09:01Z","timestamp":1623424141000},"page":"e25859","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["A case report of malignant hyperthermia in a patient with myotonic dystrophy type I"],"prefix":"10.1097","volume":"100","author":[{"given":"Seon Woo","family":"Yoo","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Jeonbuk National University Medical School"},{"name":"Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seon Ju","family":"Baek","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Jeonbuk National University Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Chan","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Jeonbuk National University Medical School"},{"name":"Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1310-790X","authenticated-orcid":false,"given":"A Ram","family":"Doo","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Jeonbuk National University Medical School"},{"name":"Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/ALN.0000000000002490","article-title":"Succinylcholine use and dantrolene availability for malignant hyperthermia treatment: database analyses and systematic review","volume":"130","author":"Larach","year":"2019","journal-title":"Anesthesiology"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/ALN.0000000000001877","article-title":"Malignant hyperthermia susceptibility and related diseases","volume":"128","author":"Litman","year":"2018","journal-title":"Anesthesiology"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/WCO.0000000000000592","article-title":"Malignant hyperthermia: still an issue for neuromuscular diseases?","volume":"31","author":"De Wel","year":"2018","journal-title":"Curr Opin Neurol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"C358","DOI":"10.1152\/ajpcell.00052.2019","article-title":"A central core disease mutation in the Ca(2+)-binding site of skeletal muscle ryanodine receptor impairs single-channel regulation","volume":"317","author":"Chirasani","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/archneur.61.1.106","article-title":"Multiminicore disease in a family susceptible to malignant hyperthermia: histology, in vitro contracture tests, and genetic characterization","volume":"61","author":"Guis","year":"2004","journal-title":"Arch Neurol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1213\/ane.0b013e3181a7c8e5","article-title":"The myotonias and susceptibility to malignant hyperthermia","volume":"109","author":"Parness","year":"2009","journal-title":"Anesth Analg"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1213\/ane.0b013e3181aa5cf6","article-title":"Malignant hyperthermia and muscular dystrophies","volume":"109","author":"Gurnaney","year":"2009","journal-title":"Anesth Analg"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/pan.12120","article-title":"Myotonic dystrophies type 1 and 2: anesthetic care","volume":"23","author":"Veyckemans","year":"2013","journal-title":"Paediatr Anaesth"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00131402-200212000-00004","article-title":"Current concepts in malignant hyperthermia","volume":"4","author":"Finsterer","year":"2002","journal-title":"J Clin Neuromuscul Dis"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/mus.880150619","article-title":"Dominantly inherited malignant hyperthermia (MH) in the King-Denborough syndrome","volume":"15","author":"Isaacs","year":"1992","journal-title":"Muscle Nerve"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/pan.13130","article-title":"Anesthesia-induced rhabdomyolysis or malignant hyperthermia: is defining the crisis important?","volume":"27","author":"Gray","year":"2017","journal-title":"Paediatr Anaesth"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00000542-199404000-00008","article-title":"A clinical grading scale to predict malignant hyperthermia susceptibility","volume":"80","author":"Larach","year":"1994","journal-title":"Anesthesiology"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1213\/00000539-198910000-00015","article-title":"Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group","volume":"69","author":"Larach","year":"1989","journal-title":"Anesth Analg"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","article-title":"Mutations in RYR1 in malignant hyperthermia and central core disease","volume":"27","author":"Robinson","year":"2006","journal-title":"Hum Mutat"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s12630-017-0865-5","article-title":"Malignant hyperthermia susceptibility in patients with exertional rhabdomyolysis: a retrospective cohort study and updated systematic review","volume":"64","author":"Kraeva","year":"2017","journal-title":"Can J Anaesth"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1152\/physiolgenomics.00126.2016","article-title":"Pharmacogenetics and pathophysiology of CACNA1S mutations in malignant hyperthermia","volume":"49","author":"Beam","year":"2017","journal-title":"Physiol Genomics"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/humu.23635","article-title":"STAC3 variants cause a congenital myopathy with distinctive dysmorphic features and malignant hyperthermia susceptibility","volume":"39","author":"Zaharieva","year":"2018","journal-title":"Hum Mutat"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00019052-199510000-00013","article-title":"Discordance between phenotype and genotype in malignant hyperthermia","volume":"8","author":"MacLennan","year":"1995","journal-title":"Curr Opin Neurol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1212\/WNL.49.6.1646","article-title":"Anesthetic and surgical complications in 219 cases of myotonic dystrophy","volume":"49","author":"Mathieu","year":"1997","journal-title":"Neurology"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0889-8537(02)00011-1","article-title":"Malignant hyperthermia and myotonic disorders","volume":"20","author":"Rosenbaum","year":"2002","journal-title":"Anesthesiol Clin North Am"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/CND.0b013e3181520095","article-title":"Myotonic dystrophy type 1 presenting with ventilatory failure","volume":"9","author":"Souayah","year":"2007","journal-title":"J Clin Neuromuscul Dis"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/bja\/57.11.1119","article-title":"Anaesthetic problems in myotonic dystrophy. A case report and review of the Aberdeen experience comprising 48 general anaesthetics in a further 16 patients","volume":"57","author":"Aldridge","year":"1985","journal-title":"Br J Anaesth"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/bja\/64.1.110","article-title":"Exaggerated physiological responses to propofol in myotonic dystrophy","volume":"64","author":"Speedy","year":"1990","journal-title":"Br J Anaesth"},{"key":"R24-20250504","first-page":"107952","article-title":"Sensitivity to rocuronium-induced neuromuscular block and reversibility with sugammadex in a patient with myotonic dystrophy","volume":"2012","author":"Kashiwai","year":"2012","journal-title":"Case Rep Anesthesiol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/bja\/54.5.529","article-title":"Hazards of neostigmine in patients with neuromuscular disorders. Report of two cases","volume":"54","author":"Buzello","year":"1982","journal-title":"Br J Anaesth"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1213\/ANE.0000000000000062","article-title":"Anesthetic drugs and onset of malignant hyperthermia","volume":"118","author":"Visoiu","year":"2014","journal-title":"Anesth Analg"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00000542-198103000-00020","article-title":"Sevoflurane triggers malignant hyperthermia in swine","volume":"54","author":"Shulman","year":"1981","journal-title":"Anesthesiology"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1213\/00000539-199806000-00037","article-title":"Human malignant hyperthermia associated with desflurane anesthesia","volume":"86","author":"Allen","year":"1998","journal-title":"Anesth Analg"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1399-6576.2011.02573.x","article-title":"The severity of sevoflurane-induced malignant hyperthermia","volume":"56","author":"Migita","year":"2012","journal-title":"Acta Anaesthesiol Scand"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025859","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:36:02Z","timestamp":1746336962000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025859"}},"subtitle":["A CARE-compliant article"],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":29,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000025859","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,6,11]]},"assertion":[{"value":"2021-02-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}